在心房动和功能障碍患者中治疗抗凝血:系统性审查
Anish Kumar1, Chander Kumar1, Ajay Kumar2
1Medicine, Liaquat University of Medical and Health Sciences, Jamshoro 76090, Sindh, Pakistan.
World journal of experimental medicine
|January 12, 2026
概括
在心房动 (AF) 患有功能障碍的患者中管理抗凝药是复杂的. 建议在中度慢性病中使用阿皮克萨班,以平衡中风和出血风险.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心房动 (AF) 是一种常见的心律失常,与高发病率和死亡率有关,特别是与脏问题并存.
- 抗凝药对于预防AF血栓至关重要,但因功能障碍而复杂,影响药物水平和出血风险.
研究的目的:
- 为指导临床医生在治疗患有功能障碍的AF患者的抗凝药管理.
- 优化治疗策略,改善这一高风险群体的治疗结果.
主要方法:
- 在遵守PRISMA指南的基础上进行系统审查.
- 数据提取包括患者人口统计,功能,抗凝剂剂量和结果.
- 质量评估使用了柯克兰偏差风险2.0和纽卡斯尔-太华尺度.
主要成果:
- 对16项研究的分析为抗凝血药物的建议提供了信息.
- 建议在中度慢性病中使用阿皮克萨班,并在末期病中谨慎使用.
- 个性化治疗对于平衡血栓和出血风险至关重要.
结论:
- 在患有功能障碍的AF患者中,抗凝剂管理具有挑战性,但对于降低中风风险至关重要.
- 证据支持在特定的功能障碍类别中使用阿皮克萨班,强调了需要量身定制的方法.
相关概念视频
Venous Thrombosis III: Interprofessional Care
273
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
273
Factors Affecting Renal Clearance: Renal Impairment
412
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
412
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
202
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
202
Renal Failure: Dose Adjustments
426
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
426
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
255
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
255


